Posts

Showing posts with the label Atmanirbhar Bharat

BEL to exhibit 30 products developed under Atmanirbhar Bharat

Image
BEL to exhibit 30 products developed under Atmanirbhar Bharat:  Bharat Electronics Limited (BEL)   is ready to display its state-of-the-art products and systems during upcoming Aero India. BEL will present its land and naval products and systems, comprising   QRSAM radars . The PSU will also display communication and laser-based products, including MODEM for a troposcatter communication system.     "The products and systems are clustered as airborne and space application, satellite and space application, products and systems for self-reliance  (Aatmanirbhar Bharat) , high-performance computing and artificial intelligence systems, land and naval products and systems, communication and laser-based products, non-defence/diversification and outdoor display products. The technologies are in the area of airborne and space/satellite application, and include self-protection suite with DIRCM (with foreign ToT), handheld field signal generator, airborne and ground sp...

“Atmanirbhar Bharat means India is an active participant in the global economy”: Ravi Shankar Prasad

“Atmanirbhar Bharat means India is an active participant in the global economy”: Ravi Shankar Prasad : Shri Ravi Shankar Prasad, Union Minister for Communications, Electronics & Information Technology and Law & Justice, Government of India clarified that Atmanirbhar Bharat doesn’t mean isolated India. “Atmanirbhar Bharat means India is an active participant in the global economy and this is the crux of the whole PLI scheme.

Centre Launches Serum Institute’s Pneumococcal Vaccine Pneumosil

Image
Centre Launches Serum Institute’s Pneumococcal Vaccine Pneumosil:  Union Health Minister Harsh Vardhan   launched the country's first pneumococcal conjugate vaccine 'Pneumosil' developed by Serum Institute of India in collaboration with partners like the Bill and Melinda Gates Foundation.   On the occasion, Vardhan remarked that the vaccines are used in 170 countries and every third child in the world is immunised with the manufacturer's shots, the health ministry said in a statement. The minister further said that SIIPL developed and got license of the first indigenous Pneumococcal Conjugate Vaccine (PCV) from the government during COVID-19 pandemic lockdown, in line with Prime Minister Narendra Modi's vision of Atmanirbhar Bharat', it said. Serum Institute's first indigenous Pneumococcal Conjugate Vaccine will be available in the market under the brand name 'Pneumosil' at an affordable price in single dose (vial and pre-filled syringe) and multidos...